new glp 1 gip drug Understand GLP-1/GIP Dual Agonist Tirzepatide and Its Effect on Current Weight Loss Therapy Medscape | The investigational triple
Description
By enhancing fat oxidation and reducing lipid accumulation, it shows potential in addressing conditions such as metabolic dysfunctionassociated fatty liver disease (MAFLD) and non-alcoholic steatohepatitis (NASH)
[DOI] [PubMed] [Google Scholar] 4.Drucker DJ
-1775582746855.png&w=3840&q=75)
Pharmacies are having trouble keeping them in stock and patients are complaining that they cant get them
No, GLP-1 and dual-agonist peptides are contraindicated during pregnancy and breastfeeding
